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Available online 30 July 2016Indirect evidence suggests that adipose tissue-derived stromal cells (ASCs) possess different physiological and bi-
ological variations related to the anatomical localization of the adipose depots. Accordingly, to investigate the in-
fluence of the tissue origin on the intrinsic properties of ASCs and to assess their response to specific stimuli, we
compared the biological, functional and ultrastructural properties of two ASC pools derived frommediastinal and
subcutaneous depots (thoracic compartment) bymeans of supplements such as platelet lysate (PL) and FBS. Sub-
cutaneous ASCs exhibited higher proliferative and clonogenic abilities than mediastinal counterpart, as well as
increased secreted levels of IL-6 combinedwith lower amount of VEGF-C. In contrast, mediastinal ASCs displayed
enhanced pro-angiogenic and adipogenic differentiation properties, increased cell diameter and early autophagic
processes, highlighted by electron microscopy. Our results further support the hypothesis that the origin of adi-
pose tissue significantly defines the biological properties of ASCs, and that a homogeneric function for all ASCs
cannot be assumed.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Adipose tissue is a versatile organ not limited to the lipidic function,
but also exerting significant endocrine and inflammatory activity and
influencing vascular function (Meissburger et al., 2016; Chudek and
Wiecek, 2006). Froma physiological standpoint, the development of ad-
ipose tissuewithin the body is not univocal andmany factors cooperate
to orchestrate its varied distribution, including genetic background andl cells; PL, Platelet lysate; CM,
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. This is an open access article undervariations due to clinical conditions (Gesta et al., 2007). Furthermore,
the adipose tissue is highly heterogeneous and recent clinical evidence
indicates that both the compartmentalization and anatomical deposi-
tion of fat depots considerably differ inmetabolic and physiological pro-
files (Kwok et al., 2016; Lee et al., 2013). These dissimilarities have been
ascribable to a different developmental origin and epigenetic regulation,
implying profound differences in depot-specific patterning genes and
pathway activity mainly related to the anatomic region of origin
(Gesta et al., 2006; Pinnick et al., 2014; Collas, 2010; Karantalis and
Hare, 2015). Notably, differences in adipose depots also cause clinical
consequences in those pathologies where fat tissue exerts a pathophys-
iological role such as endocrinological, metabolic and cardiac disorders,
obesity, diabetes and cancer (Lapidus et al., 1984; Despres, 2006; Lim
andMeigs, 2013). For instance, a clear association between cardiovascu-
lar risk and type of fat depot has been clearly elucidated. Visceral rather
than subcutaneous adipose tissue has been suggested to be directly pro-
portional to adverse cardiac and cancer risk due to the prevalence of ox-
idative and inflammatory systemic states (Pou et al., 2007; Misra et al.,
1997; Harada et al., 2015; Chau et al., 2014).
Recently, work has been focused on the adipose tissue-derived stro-
mal cell (ASCs) population, since retrieval is straight forward and non-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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properties of ASCs have only been assessed by indiscriminate isolation
frommostly white fat depots. Little has been done to evaluate potential
intrinsic differences between anatomic depot regions. By only consider-
ing all ASC populations as functionally and biologically equivalent, this
has consequently led to incomparable and sometimes contradictory re-
sults. Yet, several reports, while supporting intrinsic differences be-
tween fat depots, indirectly suggest divergences in ASCs. Abdominal
ASCs demonstrate diminished susceptibility to apoptosis (Toyoda et
al., 2009), whereas those derived from pericardium, omentum and
groin display different phenotype (Russo et al., 2014). According to
the anatomical location of the fat, ASCs could differently exhibit surface
epitopes as well as cell yield, ability to differentiate and morphological
properties. This may have important consequence on altered response
to pharmaceutical treatments (Russo et al., 2014; Perrini et al., 2008;
Tchkonia et al., 2002; Gibellini et al., 2015; Schweizer et al., 2015;
Elahi et al., 2016; Luna et al., 2014).
Differences between fat depots grown under different conditions are
not well known. We have investigated the potential of human medias-
tinal depot as a novel ASC pool (Siciliano et al., 2015a,b,c), including the
treatment with hemoderivate agents, such as platelet lysate (PL)
(Siciliano et al., 2015a,b,c). In this study, we aimed to compare ASCs de-
rived from the mediastinal region (fat inside the rib cage) to ASCs de-
rived from the subcutaneous adipose tissue (fat outside the rib cage).
Two different supplements, PL and FBSwere used to unveil their biolog-
ical features. Our study revealed functional differences in ASCs derived
from the mediastinal region respect to the subcutaneous, showing en-
hanced pro-angiogenic features, whereas subcutaneous displayed
higher proliferative and clonogenic abilities and a greater degree of au-
tophagy associated structures.
2. Materials and methods
2.1. Surgical specimen collection
Surgical procedures were conducted at “Sant'Andrea”Hospital, Rome.
The study was approved by the Ethical Committee of the hospital (refer-
ence 49_2013/28.01.2016).Written informed consent was obtained from
patients, before starting all the surgical and laboratory procedures. The
methodology described in this study has been conducted in compliance
with the tenets of the Declaration of Helsinki for experiments involving
human tissues.Medical records of each patientwere collected in a clinical
database. All data were de-identified and analysed anonymously. Previ-
ous malignancy, chemotherapy, inflammatory states, diabetes or obesity
were considered as exclusion criteria. Bioptical samples of mediastinal
and subcutaneous adipose tissues were collected from patients (12
male and 10 female patients, mean age of 65.13± 9.82) undergoing tho-
racic surgery (pulmonary amartochondroma), aswepreviously described
(Siciliano et al., 2015a,b,c). Briefly, subcutaneous fat biopsieswere obtain-
ed just after skin incision, whereas mediastinal samples from the anterior
mediastinum outside the pericardium. The identification of both fat de-
pots was performed by eye and biopsies (a minimal amount of 10 g)
were always withdrawn from non-necrotic areas, respecting the estheti-
cal anatomical fat distribution of patients. The samples were collected by
using an electrocautery, in order to avoid an excessive amount of erythro-
cytes in the specimen, known to influence the quality of the in vitro cul-
ture and cell yield (Siciliano et al., 2015c).
2.2. Isolation, characterization and cell growth of subcutaneous and medi-
astinal ASCs
Both subcutaneous and mediastinal ASCs were isolated as we previ-
ously described (Siciliano et al., 2015a,b,c). Briefly, tissue specimens
were enzymatically digested using 0.05% Trypsin/0.02% EDTA (Biowest,
Nuaillé, France, Cat. N. X0930-100)/1mg/ml collagenase type-I solution
(Gibco, Monza, Italy, Cat. N. 17100) for 45 min at 37 °C. The pellet wasresuspended in complete growth medium (low and high glucose
DMEM, respectively/1% penicillin–streptomycin/1% glutamine/1% non-
essential amino acids (all Biowest, Nuaillé, France) supplemented with
either 10% FBS or the patented GMP-compliant Platelet Lysate (PL,
Mesengen MES-R, Italy) (Siciliano et al., 2015a,b,c; Carducci et al.,
2016) and allowed to adhere in the incubator for 3 days. ASC cultures
were maintained at a cell density 4000 cells/cm2 and passaged when
reached 80–90% of confluence. Cell growth/viability was assessed by
Trypan Blue (Siciliano et al., 2015a; De Falco et al., 2013) and measured
by the automatic cell counter Countess® (Life Technology, Monza,
Italy). The number of doubling cells was calculated as the following
ratio: 3.322 log10 N/N0 (N is the final number of cells obtained and N0
is the number of cells plated) (De Falco et al., 2013). CM were collected
from cultures maintaining consistent ratios of cell densities and media
volumes between passage 3 and 6 and stored at−80 °C until use.
Immunophenotype was assessed by FACS Analysis, as we already
described (Siciliano et al., 2015a,b,c). Briefly, cells were stained with
the following panel of primary antibodies: CD105, CD44, CD90, CD45,
CD117, CD133 (all Abcam Cat. N. ab44967, ab6124, ab23894, ab10559,
ab5506, ab19898), CD31 (Sigma, St. Louis, MO, USA, Cat. N. P8590),
CD34 (Miltenyi Biotech, Calderara di Reno, Bologna, Italy, Cat. N. 130-
081-001), CD13 and CD73 (Biolegend, San Diego, CA, USA Cat. N.
301,703 and 344005, respectively). Anti-Rabbit Alexafluor-488 (Molec-
ular Probe), mouse FITC-conjugated anti-mouse IgG (H + L) (Jackson
ImmunoResearch, Suffolk, UK) and mouse IgG2a (Miltenyi Biotech,
Calderara di Reno, Bologna, Italy) were used as secondary antibodies.
Samples were acquired by cytofluorimeter (FACSAria II, BD, San Jose,
CA, USA) and analysed by DiVa Software (v6.1.1, BD, San Jose, CA, USA).
Secondary colony forming efficiency assaywasperformed aswe pre-
viously described (Siciliano et al., 2015a,b,c; Menna et al., 2014). Briefly,
ASCswere seeded at passage 3 at lowdensity (10 cells/cm2) in complete
medium and incubated for 14 days at 37 °C. Colonies produced were
fixed with 4% paraformaldehyde and then stained with Giemsa
(Sigma,Milan, Italy) for 1 h and counted by opticalmicroscope. A cluster
with N50 cells was considered as a colony. For adipogenic trans-differ-
entiation test, ASCswere cultured for 2–3weeksusing StemPro®Adipo-
genesis Differentiation kit (GIBCO, Grand Island, NY, USA, cell density
1 × 104 cells/cm2, Cat. N. A10070-01) (Siciliano et al., 2015a,c). Accumu-
lation of lipid droplets was evaluated by Oil Red Oil staining (Sigma-Al-
drich, St. Louis, MO, USA, Cat. N. 01391-500ml). For the quantification of
the adipogenesis, at least 10 randomly selected fields were observed
under an optical microscope and the number of positive adipocytes
were counted and expressed as following: differentiation ratio (%) =
(Number of transdifferentiated ASCs / total cell number) × 100.
For detailed analysis of migration assay, cytokine profile, tubule for-
mation assay, immunomodulatory properties and transmission electron
microscopy, see Supplementary methods.
2.3. Statistical analysis
Data were analysed by GraphPad Prism 5 software (San Diego, USA)
using the unpaired student t-test for comparison between any two
datasets. P values b 0.05 were considered to be significant. Data are
expressed asmeans ± SD, unless specified. Experiments were repeated
at least three times.
3. Results
3.1. Proliferation and clonogenic activity reflect biological differences be-
tween mediastinal and subcutaneous ASCs
In order to compare ASC populations derived from two distinct and
anatomically distant sources of adipose tissue, we isolated bothmedias-
tinal and subcutaneous ASCs (fat inside and outside the rib cage, respec-
tively). Interpatient variability was reduced by collecting surgical
biopsies of both adipose depots from the same patient. Intrinsic
344 C. Siciliano et al. / Stem Cell Research 17 (2016) 342–351biological differences and behaviour were assessed by expanding ASC
cultures under two conditions, platelet lysate (PL), a hemoderivate
enriched in growth factors and cytokines (Siciliano et al., 2015a,b,c;
Iudicone et al., 2014), or foetal bovine serum (FBS). Both are routinely
used for in vitroASC expansion andmaintenance, and alsodifferently in-
fluence stromal biological properties (Siciliano et al., 2015a). A summa-
ry of the experimental design is described in Fig. 1A.
Given that high mitotic activity is recognized as a distinct feature of
ASCs (Friedenstein et al., 1976; Friedenstein et al., 1966), we evaluated
the potency of PL or FBS between passages 2 and 4 to cause proliferation,
which generally corresponds to the log phase of ASC growth (Marquez-
Curtis et al., 2015).We observed a significant difference in the number of
doubling cells between subcutaneous andmediastinal ASCs at passage 4
in the presence of PL (Fig. 1B–C, P= 0.038). Conversely, no significant
difference in cell proliferation was found in presence of FBS (Fig. 1B,
P N 0.05 all passages). The phenotypic analysis of cells from the fourth
passage by flow cytometry, revealed that both subcutaneous and medi-
astinal ASCs displayed a homogenous and similar phenotype for the
main surface antigens. This defined the stromal and the endothelial/he-
matopoietic fraction (Siciliano et al., 2015a,c; Dominici et al., 2006)
with either stimulus (PL or FBS). Both ASC pools expressed comparable
positive levels of CD44, CD90, CD105, CD13 and CD73, and similar nega-
tive profile for CD31, CD117, CD45 and CD34 (Supplementary Fig. 1A–B).
Interestingly, the number of secondary colonies generated at pas-
sage 3 by subcutaneous ASCs in presence of FBSwas significantly higher
compared to that formed by mediastinal ASCs (Fig. 2A, D–E, P= 0.04).
Whereas, no differences between the two ASC pools was observed
after preconditioning with PL (Fig. 2A, B–C P N 0.05).Fig. 1. A–C. Experimental design 1 and ASC growth curve. (A) The cartoon displays the experim
cultured subcutaneousASCs show a significantly higher number of doubling cells compared tom
number of doubling cells was calculated according to the following formula: 3.322 log10 N/N0
tissue. *P b 0–05.Assessment of the ability of two ASC pools to migrate, showed com-
parablemigratory activity either in presence of PL or FBS (Supplementa-
ry Fig. 2A–E, P N 0.05). As expected, the treatment with PL significantly
increased the number of migrated ASCs compared to FBS regardless of
the adipose depot (Supplementary Fig. 2A–E both P b 0.0001).
3.2. Conditioned media derived from subcutaneous and mediastinal ASCs
show comparable immunostimulatory capacity, but different angiogenic
and paracrine properties
Considering the ability of ASCs to promote angiogenesis and regener-
ationboth in vitro and in vivobyparacrine effects in several pathologies in-
cluding heart failure, diabetes and cancer (Ohnishi et al., 2007; Gu et al.,
2014; Zimmerlin et al., 2013), we analysed the secretome profile of their
CMbyquantifying the levels ofmultiple angiogenic soluble factors, includ-
ing the VEGF and TGF-β families, several interleukins and growth factors.
We found that only upon treatmentwith PL, higher levels of IL-6 or VEGF-
C were secreted by subcutaneous or mediastinal ASCs, respectively (Fig.
3A–B, P= 0.016 and P= 0.048, respectively). No significant difference
was observed regarding the remaining cytokines/growth factors either
in presence of PL and FBS (Supplementary Fig. 3A–D, all P N 0.05).
Given the dual ability of ASCs to promote angiogenesis (Kwon et al.,
2014) and to act as immunomodulators (Aggarwal and Pittenger, 2005;
Meisel et al., 2004; Krampera et al., 2006), we evaluated both the in vitro
angiogenic potential and the possible effect on PBMC activation of the
same CM derived from PL and FBS-cultured ASCs. Accordingly, we test-
ed the influence of the ASC-derived CMon the ability of HUVECs to form
networks, and their specific capacity to modulate PBMCs proliferationental plan 1 designed for the study. (B) ASC growth trend until passage 4. Platelet lysate-
ediastinal ASCs. (C) FBS doesnot reproduce similar effect between the twoASCspools. The
, where N is the number of cells obtained and N0 is the number of cell plated. AT, adipose
Fig. 2.A–E. Colony Forming Unit-fibroblast assay (CFU-F). (A) The graph shows that the number of secondary colonies generated at passage 3 by subcutaneous ASCs is significantly higher
compared to that produced bymediastinal ASCswhen treating with FBS. Conversely, no significant difference was found if ASCsweremaintained in Platelet lysate. Representative images
of the clones generated upon PL (B–C) or FBS (D–E) treatment after Giemsa staining. Magnification 5×. *P b 0.05.
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showed that only CM derived from mediastinal ASCs, significantly in-
creased the number of fenestrae and total network length (either in
presence of PL or FBS), compared to those derived from subcutaneous
ASCs (Fig. 4A–F, fenestrae P=0.0072 and P=0.0005, respectively; net-
work length P= 0.045 and P= 0.022, respectively). No difference was
observed regarding the number of branching points. Additionally, in
order to verify whether or not the improved angiogenic capacity of
CM derived from the mediastinal ASC pool was related to VEGF-C, we
added a VEGF-C neutralizing antibody to the supernatants before
performing matrigel assay on HUVECs. Results showed a significant re-
duction of both fenestrae and tubule length respect to untreated CM, and
independently from treatment (Fig. 4G–H all P b 0.001).Fig. 3.A–B. Secretomeprofile of conditionedmedia derived from subcutaneous andmediastinal
and mediastinal ASCs secrete significantly higher levels of IL-6 and VEGF-C, respectively and nMoreover, CM derived from ASCs, positively stimulated or decrease
the number of cell divisions of PBMCs over the time similarly to the
trend exerted by PL or FBS alone and regardless the tissue of origin (Sup-
plementary Fig. 4A–B, P N 0.05). The percentage of the CD4+ and CD4−
subpopulations was not affected (data not shown).
3.3. Influence of the tissue origin on adipogenic differentiation and ultra-
structural characteristics
We then investigated whether the source of adipose tissue could in-
fluence the intrinsic ASC differentiation potential towards the
adipogenic lineage. Results showed that both ASC pools exhibited
equal adipogenic differentiation ratio independently from treatmentASC cultures. (A) The graphdisplays that only uponplatelet lysate treatment subcutaneous
ot when cultured with FBS (B).
Fig. 4.A–H. Angiogenic ability of CMderived from subcutaneous andmediastinal ASC cultures onHUVECs. (A–B) The graphs show that only CMderived frommediastinal ASCs are able to
significantly increase the number of fenestrae and tube length formed byHUVECs in amatrigel assay regardless the treatment. (C–F) Representative optical images of HUVECs in amatrigel
assay cultured with CM derived from the two ASC pools. (G) The graph shows that the pre-treatment with the VEGF-C neutralizing antibody of the CM derived from themediastinal ASC
pool is able to significantly reduce thenumber of loops and tube length. (H)Representative optical images of thematrigel assay in absence and inpresence of VEGF-Cneutralizing antibody.
Magnification 5×. **P b 0.01, #P b 0.0001.
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displayed a significantly increased proportion of adipogenic cells com-
pared to those cultured in FBS (P= 0.04).
Additionally, we evaluated the intrinsic ultrastructure characteris-
tics performing a qualitative analysis by performing Transmission elec-
tron microscopy (TEM). Given the influence of the genetic background
on the ultrastructural features of the ASC population (Gesta et al.,
2007), we compared the two ASC pools derived from a single patient
(patient 55) according to the experimental design 2 (Supplementary
Fig. 5A). The analysis confirmed that bothASC pools appeared heteroge-
neous. Morphological phenotypewas not terminally committed (for in-
stance towards a specific lineage), but interestingly mediastinal ASCs
showed a significant higher average diameter compared to the subcuta-
neous pool regardless of the treatment (Supplementary Fig. 5B, P =
0.0011 PL; P = 0.0005 FBS). In addition, PL-cultured subcutaneous
ASCs displayed a large number of autophagosomes engulfed withcellular components and autolysosomal vacuoles (Fig. 6A, C), whereas
in mediastinal ASCs a greater number of primary lysosomes (identified
as electrondense black vacuoles) and dilated cisternae of the endoplas-
mic reticulum, that were centrally localized and in the proximity of
the primary lysosomes, predominated (Fig. 6B, D). Interestingly, in the
subcutaneous ASC pool the euchromatin coexisted with a discrete
amount of condensed heterochromatin (Fig. 6E), whereas finely dis-
persed and unclamped euchromatin was clearly present in the medias-
tinal counterpart (Fig. 6F). Nuclear indentations were equally visible
(Fig. 6E–F). Cellular surface in both PL-cultured ASC populations was
characterized by thepresenceof numerousnon-intestinal-likemicrovil-
li associated to blebs, as well as filopodia and microvesicles (Fig. 6G–H).
In addition, mitochondria present in PL-cultured mediastinal ASCs
displayed active physiological characteristics, such as abundant non-di-
lated crests and regular shape, in contrast to the subcutaneous ASCs
where crests were less visible (Fig. 6I–L).
Fig. 5. A–B. Adipogenic differentiation of ASC pools. (A) The graph displays that the ratio of ASCs transdifferentiated towards the adipogenic lineage is similar in both pools regardless the
treatment. Only ASCs derived from the mediastinal fat tissue exhibit higher ratio of transdifferentiated cells in platelet lysate compared to FBS. (B) Representative optical images of ASCs
transdifferentiated in adipogenic cells and stained with Oil Red Oil. Magnification 10×. *P b 0.05.
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microvesicles and blebs appeared as short and small protrusions uni-
formly distributed, accompanied by less numerous filopodia and vacu-
oles (Fig. 7A). The mediastinal counterpart showed a greater number
of small autolysosomal vacuoles, filopodia, as well as few primary lyso-
somes and blebs (Fig. 7B). Of note, both ASC pools exhibited indented
nuclei (repeated invaginations of the nuclear membrane towards the
cytoplasmic membrane) mainly containing a finely dispersed and
unclamped euchromatin (Fig. 7A–B). Mediastinal ASCs also displayed
mitochondrial crests which were barely visible and several lamellar
bodies in the form of onion-like structures, in contrast to well-defined
mitochondrial lamellar crests and absent lamellar bodies observed in
the subcutaneous pool (Fig. 7C–D).
4. Discussion
In this study, we evaluated if different and distant anatomic regions
of fat depots, albeit limited to the thoracic cavity, might reflect a hetero-
geneous array of biological, functional and ultrastructural features of
ASCs. Our results support previous findings on putative differences be-
tween ASC pools isolated from multiple adipose sources (Ritter et al.,
2015; Baglioni et al., 2012), but additionally they highlighted for the
first time novel insights on intrinsic biological variations between
intra- and extra-thoracic adipose compartments, indicating a different
behaviour in relation not only to tissue of origin but also to the type of
treatment employed. Notably, we described the properties of the medi-
astinal fat, considered as cardiac visceral fat with a different ontogenetic
origin with respect to the subcutaneous depot (Chau et al., 2014; Atalar
et al., 2013). To date, the function and biology of the mediastinal tissue,
and particularly of the corresponding ASC pool, is poorly defined. This is
likely due to technical limitations, as it represents a less accessible
source of adipose tissue respect to other body regions. Yet, the medias-
tinal fat exerts ametabolic role in situ antagonistic to the protective sub-
cutaneous counterpart (Chau et al., 2014; Atalar et al., 2013; Sironi et al.,
2012; Sicari et al., 2011; Cheung et al., 2013). Remarkably, its enhanced
deposition has been significantly associated to cardiovascular risk. Our
study has implemented these differences in the thoracic cavity, as we
showed that the angiogenic capability of mediastinal ASCs stands out
from other properties, evoking the potential physiological/metabolical
relevance of the mediastinal fat according to its proximity to the heart
(Siciliano et al., 2015b,c; Baglioni et al., 2012; Patel et al., 2013). In con-
trast to other reports (Baglioni et al., 2012; Li et al., 2014), we describedthat the conditioningwith specific stimuli (PL or FBS) unveils changes in
stem cell plastic ability or functionality. This is dependent upon the in-
trinsic biological background of ASCs, and distinguishable from their
common biological properties. Conditioning with supplements alone
was insufficient to determine all of the biological differences observed.
Accordingly, PL is known to be a superior inducer of ASC growth com-
pared to FBS (Siciliano et al., 2015a; Bieback, 2013). Nevertheless only
PL-cultured subcutaneous ASCs displayed a proliferative advantage
compared to themediastinal counterpart. This enhancedmetabolic pro-
file of subcutaneous ASCs, which was amplified by PL treatment, likely
resembled the biological and physiological role played by the subcuta-
neous fat, such as exerting a feeder-like support for skin-resident cells
duringwoundhealing processes (Richmond andHarris, 2014). Interest-
ingly, the same subcutaneous pool showed superior clonogenic activity
(specifically a secondary colony forming efficiency capacity) compared
to FBS treated mediastinal counterpart. This does not influence per se
the capacity to stimulate ASCs to clone as PL (Siciliano et al., 2015a). Ad-
ditionally, we found that the two ASC pools secreted partially different
paracrine microenvironments, in addition to contrasting pro-angiogen-
ic properties. Despite the fact that the majority of the secretome profile
is largely shared by both populations, CMderived from PL-cultured sub-
cutaneous ASCs contained higher levels of IL-6, but a decreased amount
of VEGF-C compared to CMderived frommediastinal ASCs. Such feature
conferred enhanced angiogenic ability inmediastinal ASCs regardless of
the treatment. Interestingly, this was strictly related to VEGF-C, since
the use of the neutralizing antibody significantly reduced the pro-angio-
genic property. As we have already shown that IL-6 is absent in media
supplement with 10% PL or FBS (Carducci et al., 2016), it is likely that
the dissimilar combination of growth factors and/or cytokines between
PL and FBS modulates the production of IL-6 in the two ASC pools, thus
emphasising an intrinsic diversity between the two niches related to the
anatomical region. Recently, the analysis of the secretomeprofile gener-
ated by ASCs has shifted researchers' attention to the clinical meaning
(Feisst et al., 2015).More importantly to the role exerted by ASCs during
inflammation. In this regard, the ASC pool is able to respond to inflamed
microenvironments developed by a damaged tissue by combining anti-
inflammatory humoral factors and angiogenic function within the adi-
pose tissue (Tanaka, 2015; Han et al., 2015). Although the nature of
this cross-talk requires further investigation, it undoubtedly involves
the activation of specific signalling pathways such as PPAR-γ, ERK or
p38 (Ye and Gimble, 2011), resulting in a reshuffling of positive and
negative consequences, spanning from an enhanced coordination of in
Fig. 6. A–L. Ultrastructure analysis of PL-cultured subcutaneous and mediastinal ASCs by electron microscopy (Patient 55). Mediastinal ASCs mainly display a greater number of primary
lysosomes (A, C), as well as regular nuclei where euchromatin is abundant (E) compared to the subcutaneous pool, where autophagosome and autolysosomal vacuoles aremore frequent
(B, D) in combinationwith irregular nuclei and a discrete amount of heterochromatin (F). (G–H) The subcutaneous counterpart displaymore advanced autophagy-associated structures, as
well as non-intestinal type microvilli, blebs and filopodia than mediastinal ASCs. Structural detail of mitochondria present in mediastinal (I) and subcutaneous ASCs (L), displaying
abundant non-dilated and barely visible crests, respectively. Atg = autophagosomes, AV = autolysosome vacuoles, M =mitochondria, ER = cisternae of endoplasmic reticulum, F =
filopodia, MVs = microvesicles, Mv = microvilli, Ly = primary lysosomes, B = blebs, N = nucleus, HC = heterochromatin, EC = euchromatin. Acronyms in TEM panels indicate a
representative cellular structure.
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Fig. 7. A–D. Ultrastructure features of FBS-cultured subcutaneous and mediastinal ASCs by electron microscopy (Patient 55). (A) Subcutaneous ASCs display numerous short and small
cytoplasmic protrusions, blebs and microvesicles, differently from the mediastinal counterpart (B) where small autolysosomal vacuoles and filopodia predominate. Of note, in the
subcutaneous pool lamellar structures, such as onion-like bodies, are absent but accompanied by a larger number of mitochondria with well-defined lamellar crests (C) respect to the
mediastinal correspondent (D). AV = autolysosomal vacuoles, M = mitochondria, ER = cisternae of endoplasmic reticulum, Olb = onion-like bodies, F = filopodia, MVs =
microvesicles, Ly = primary lysosomes, B = blebs, N = nucleus, EC = euchromatin. Acronym in TEM panels indicates a representative cellular structure.
349C. Siciliano et al. / Stem Cell Research 17 (2016) 342–351situ tissue regeneration and metabolic homeostasis, to the inhibition of
adipogenic differentiation of the fat depot (Han et al., 2015; Cao, 2007;
Greenberg and Obin, 2006; Gimble et al., 2007). As a result, the role
played by the ASC-derived secretome (still to be properly defined)
would include functional properties beyond just inflammation
(Trayhurn and Wood, 2004; Lehrke and Lazar, 2004; Neels and
Olefsky, 2006). Remarkably, whether or not alternative sources of fat
depots exhibit similar inflammatory features, requires to be addressed.
In the light of our results, we believe that the higher amount of IL-6 se-
creted by subcutaneous ASCs could reflect their physiological ability to
trigger acute repairing processes (Richmond and Harris, 2014; Kim et
al., 2009; Fain, 2010),whereas higher levels of VEGF-C (amain regulator
of lymphangiogenesis (Iudicone et al., 2014; Huang et al., 2001)) secret-
ed by mediastinal ASCs would mirror the influence of the multiple
lymph nodes in the mediastinal region, although angiogenesis and
lymphangiogenesis represent distinct processes yet mainly controlled
by the VEGF family (Veikkola et al., 2000; Conrad et al., 2009). The poor-
ly explored interaction between fat and lymphoid tissue has been re-
ported to impact adipose tissue vascularization, as well as function
and immunological responses during inflammatory processes
(Schaffler et al., 2006).
Finally, although observed only in a single donor, we verified if dif-
ferences in the twoASC poolsmirrored dissimilar intracellular composi-
tion and organization. Ultrastructural differences have been reported to
reflect differentiative potential and mechanical properties (Pasquinelli
et al., 2007; Gonzalez-Cruz et al., 2012). Interestingly, we found that
mediastinal ASCs showed a higher cell diameter than subcutaneous
ASCs regardless of the treatment, likely coherent with a different
anatomic profile. However, the combination of the supplement and
the different origin of the fat depot seemed to influence certainultrastructural characteristics of ASCs. Accordingly, we observed chang-
es in mitochondrial cristae morphology in both ASC pools (suggesting
different oxidative states, as well as a preferential anaerobic/aerobic
metabolism on the basis of the treatment), but also increased microvilli
and microvesicles in presence of PL. These are hallmarks of a more
active autophagic flux in ASCs, and confirming the known ability of PL
to boost metabolic growth and differentiation compared to FBS (2,
38). A major prevalence of primary lysosomes (suggesting early au-
tophagy) in mediastinal ASCs, versus abundantly and accumulated
autophagosomes in the subcutaneous counterpart (markers of ad-
vanced autophagy) was found, indicating enhanced, and perhaps faster
turnover of this latter in recycling proteins or organelles. As FBS repre-
sents a cellular distress compared to PL, it is also plausible that changes
in the autophagic process observed upon FBS may reflect an attempt of
the cultures to survive in harsher microenvironments, as recently
shown upon other treatments (Molaei et al., 2015). To date, autophagy
in ASCs represents a relevant topic. It significantly contributes to the
dysregulation of the adipose tissue by controlling lipid accumulation,
and balancing white and brown fat deposition (Singh et al., 2009;
Maixner et al., 2016). Intriguingly, autophagy is enhanced in obesity
and associated to visceral fat distribution (Kovsan et al., 2011), thus en-
couraging further investigations on the ability of the stromal subset dur-
ing adipogenic commitment.
5. Conclusions
The heterogeneity and the specificity among different anatomical
depots, including new insights on the biological potency of the ASC
pool, represent a relevant issue to explore with potential clinical
implications.
350 C. Siciliano et al. / Stem Cell Research 17 (2016) 342–351The understanding of the basic intrinsic properties of ASCs by dis-
criminating between multiple sources of fat depots and the modality
by which extrinsic factors modulate their biological features, could rep-
resent a tool to elucidate either their physiological and pathological role
in many disorders.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.07.010.
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